2024-510878-24-00已完成1 期
A trial in healthy volunteers to study safety, tolerability, CS014-levels and effects in the body, after single and repeated doses of CS014, for the first time in humans.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 48
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Head of preclinical research
Scientific
Cereno Scientific AB
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Voluntary clinical trials to examine the safety and efficacy of transdermal electrical stimulation intended for retinitis pigmentosaJPRN-UMIN000021887Chiba university Department of Ophthalmology6
已完成
2 期
Voluntary clinical trials to examine the safety and efficacy of transdermal electrical stimulation intended for non-arteritic ischemic optic neuropathynon-arteritic ischemic optic neuropathyJPRN-UMIN000021889Chiba university Department of Ophthalmology3
已完成
1 期
A phase I clinical trial to investigate the safety, tolerability and efficacy of two candidate Mycobacterium avium subspecies paratuberculosis (MAP) vaccines in patients with active Crohn's diseaseDigestive SystemCrohn's diseaseISRCTN36126048HAV Vaccines Limited28
进行中（未招募）
不适用
Investigaton of Safety, Tolerability of two preparations in patients suffering from osteoarthritis of the hip or kneeEUCTR2009-010719-33-ATGebro Pharma GmbH500
已完成
2 期
Clinical study to investigate safety, tolerability, efficacy,pharmacokinetics and pharmacodynamics of inhaled multiple doses of the human GATA-3-specific DNAzyme solution SB010 in patients with moderate to severe COPD– A randomised, double-blind, parallel group, multicenter, phase IIa pilot study –J44.9Chronic obstructive pulmonary disease, unspecifiedDRKS00006087Philipps-Universität Marburg19